All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for SICKLE CELL DISEASE ASSOCIATION OF AMERICA · national organization dedicated to supporting people living with sickle cell disease

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $20,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 7

S 721
Sickle Cell Disease Comprehensive Care Act
HR 5178
Sickle Cell Disease Comprehensive Care Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
S 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
HR 247
Health Care Affordability Act of 2025
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …

Lobbying activity 4

Budget/Appropriations

Funding for federal sickle cell disease programs FY26 House and Senate Labor-HHS Appropriations bills

Medicare/Medicaid

Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease H.R. 1, One Big Beautiful Bill Act

Health Issues

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735)

Insurance

H.R. 1, One Big Beautiful Bill Act Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.